EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Aspartic Acid in Health and Disease

Milan Holeček iD

Nutrients · 17.09.2023 · 15 (18) · 4023

DOI: 10.3390/nu15184023 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 17.09.2023. Verfasst von Milan Holeček. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine in Hradec Králové, Charles University, Šimkova 870, 500 03 Hradec Králové, Czech Republic. Hauptthemen laut MEDLINE: Aspartic Acid. Die Arbeit wurde bisher 153-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Charles University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aspartic acid exists in L- and D-isoforms (L-Asp and D-Asp). Most L-Asp is synthesized by mitochondrial aspartate aminotransferase from oxaloacetate and glutamate acquired by glutamine deamidation, particularly in the liver and tumor cells, and transamination of branched-chain amino acids (BCAAs), particularly in muscles. The main source of D-Asp is the racemization of L-Asp. L-Asp transported via aspartate–glutamate carrier to the cytosol is used in protein and nucleotide synthesis, gluconeogenesis, urea, and purine-nucleotide cycles, and neurotransmission and via the malate–aspartate shuttle maintains NADH delivery to mitochondria and redox balance. L-Asp released from neurons connects with the glutamate–glutamine cycle and ensures glycolysis and ammonia detoxification in astrocytes. D-Asp has a role in brain development and hypothalamus regulation. The hereditary disorders in L-Asp metabolism include citrullinemia, asparagine synthetase deficiency, Canavan disease, and dicarboxylic aminoaciduria. L-Asp plays a role in the pathogenesis of psychiatric and neurologic disorders and alterations in BCAA levels in diabetes and hyperammonemia. Further research is needed to examine the targeting of L-Asp metabolism as a strategy to fight cancer, the use of L-Asp as a dietary supplement, and the risks of increased L-Asp consumption. The role of D-Asp in the brain warrants studies on its therapeutic potential in psychiatric and neurologic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aspartic AcidHumansAnimalsNeoplasmsBrain

Stichwörter der Autor:innen

aspartameaspartate and cell-to-cell interactionsbranched-chain amino acidsgluconeogenesisglutamate–glutamine cyclemalate–aspartate shuttleneurotransmissionoxaloacetatepurine-nucleotide cycleurea cycle

Substanzen

Aspartic Acid

Autor:innen und Institutionen

  • Department of Physiology, Faculty of Medicine in Hradec Králové, Charles University, Šimkova 870, 500 03 Hradec Králové, Czech Republic.

ORCID-Profile: Milan Holeček

Förderung

  • Charles University

Zitieren

APA

Holeček, M. (2023). Aspartic Acid in Health and Disease. Nutrients, 15(18), 4023. https://doi.org/10.3390/nu15184023

Vancouver

Holeček M. Aspartic Acid in Health and Disease. Nutrients. 2023;15(18):4023. doi:10.3390/nu15184023

BibTeX
@article{Holeek2023,
  author = {Holeček, Milan},
  title = {Aspartic Acid in Health and Disease},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {18},
  pages = {4023},
  doi = {10.3390/nu15184023}
}
Kostenlos starten →